Recent Finacing
Recent Raise
ImmunoScape develops next-generation TCR-based cell therapies and a “Seed and Boost” platform to treat difficult solid-tumor cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ImmunoScape.
